PELL Bio-Med Technology CoTPE:6949 +3.25%13 Days Inventory is 123.58 as of Dec. 2025, which is 118% above its 10-year median of 56.79. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review. Among 635 Biotechnology companies, PELL Bio-Med Technology Co ranks better than 82.2% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PELL Bio-Med Technology Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.74.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PELL Bio-Med Technology Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.05.
PELL Bio-Med Technology Co (TPE:6949) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PELL Bio-Med Technology Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PELL Bio-Med Technology Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PELL Bio-Med Technology Co Days Inventory Related Terms
PELL Bio-Med Technology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6949 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, PELL Bio-Med Technology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PELL Bio-Med Technology Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where PELL Bio-Med Technology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PELL Bio-Med Technology Co (TPE:6949) has a Days Inventory of 123.58 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PELL Bio-Med Technology Co and its competitors. This is 118% above median its historical median of 56.79. Over the past decade, PELL Bio-Med Technology Co's Days Inventory has ranged from 34.47 to 84.29. According to the industry distribution chart, PELL Bio-Med Technology Co ranks #113 out of 635 companies in the Biotechnology industry, placing it in the top 17.8%.
Is PELL Bio-Med Technology Co's Days Inventory too high?
PELL Bio-Med Technology Co's current Days Inventory of 123.58 is 118% above median its 10-year median of 56.79. Over the past 10 years, this metric has ranged from a low of 34.47 to a high of 84.29. The Biotechnology industry median Days Inventory is 183.23. PELL Bio-Med Technology Co's value of 123.58 is 32.6% below this industry median. Based on the distribution chart, PELL Bio-Med Technology Co ranks #113 out of 635 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PELL Bio-Med Technology Co ranks #113 out of 635 companies for Days Inventory. This places PELL Bio-Med Technology Co in the top 18% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.23. PELL Bio-Med Technology Co's value of 123.58 is 32.6% below this benchmark. Historically, PELL Bio-Med Technology Co's own Days Inventory has ranged from 34.47 to 84.29 over the past decade. While the company's 10-year median is 56.79 vs. the industry median of 183.23, PELL Bio-Med Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PELL Bio-Med Technology Co's current Days Inventory of 123.58 is 32.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PELL Bio-Med Technology Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PELL Bio-Med Technology Co's current Days Inventory is 123.58, which is 118% above median its own 10-year median of 56.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current Days Inventory of 123.58. The current Days Inventory is 123.58, which is 118% above median its 10-year median of 56.79 and 32.6% below the Biotechnology industry median of 183.23. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current Days Inventory is 123.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score
Get the complete analysis for TPE:6949
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6949 has been successfully added to your 
